Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 24 May 2013 for GERON CORP.
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
2
Positive at T+90
50%
Median T+90
+6.3%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -4.7%Entry US$1.42 · Close at T+365 US$1.35
- -35.3%Entry US$2.12 · Close at T+365 US$1.37
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Thomas Kiley: trading record in brief
Thomas Kiley discloses dealings in 4 companies, chiefly Geron Corp, Connetics Corp and Paratek Pharmaceuticals, Inc. Between 30 December 2005 and 22 May 2013, the trades on record add up to 41 filings.
The open-market record is one-sided, with 2 purchases worth €150k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 25 share grants and 5 option exercises.
Most recently, on 24 May 2013, the filings show a transaction in Geron Corp. The clock since the last published purchase (23 November 2011) now reads 5,448 days. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Thomas Kiley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations39 total
53,156 shares0Common StockSEC:0000886744-13-000066:0
2,500 shares0Common StockSEC:0000886744-13-000010:0
16,666 shares@ US$1.95Common StockSEC:0001209191-12-052026:0
5,128 sharesCommon StockSEC:0000947871-12-000188:0
9,615 sharesCommon StockSEC:0000947871-12-000188:1
3,200 shares0Common StockSEC:0001181431-11-062169:0
64,275 shares@ US$1.56Common StockSEC:0000886744-11-000095:0
Canonical exit: 20 Feb 2012 (T+90)
50,000 shares@ US$2.03Common StockSEC:0000886744-11-000090:0
Canonical exit: 3 Jan 2012 (T+90)
50,000 shares@ US$2.72Common StockSEC:0001181431-11-047051:0
2,500 shares0Common StockSEC:0000886744-11-000049:0
2,500 shares0Common StockSEC:0000886744-11-000049:1
4,073 shares0Common StockSEC:0000886744-11-000035:0
6,000 shares0Common StockSEC:0000886744-11-000035:1
2,500 shares0Common StockSEC:0000886744-11-000035:2
7,500 shares0Common StockSEC:0000886744-11-000035:3
9,000 shares0Common StockSEC:0000886744-10-000091:0
9,000 shares0Common StockSEC:0000886744-10-000091:1
9,000 shares0Common StockSEC:0000886744-10-000091:2
18,000 shares0Common StockSEC:0000886744-10-000091:3
3,781 shares@ US$5.29Common StockSEC:0000886744-10-000039:0
5,625 shares0Common StockSEC:0000886744-10-000039:1
5,625 shares0Common StockSEC:0000886744-09-000088:1
20,000 shares0Common StockSEC:0000886744-09-000088:2
31,660 sharesCommon StockSEC:0001181431-09-006289:0
20,369 sharesCommon StockSEC:0001181431-09-006289:1
25 of 39 declarations
